SMSLIFE — SMS Lifesciences India Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹4.23bn
- IN₹5.30bn
- IN₹3.06bn
- 73
- 30
- 82
- 69
Annual cashflow statement for SMS Lifesciences India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 147 | 196 | 200 | 142 | 98.5 |
| Depreciation | |||||
| Non-Cash Items | 33.7 | 25.1 | 36.2 | 47 | 64.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -114 | 52.3 | -449 | -150 | -69.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 145 | 352 | -112 | 147 | 243 |
| Capital Expenditures | -234 | -356 | -512 | -486 | -209 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -36.7 | 93.2 | 440 | 173 | 24.2 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -270 | -262 | -71.4 | -313 | -185 |
| Financing Cash Flow Items | -30.9 | -25.2 | -35.4 | -35.3 | -62.9 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 124 | -25.5 | 108 | 169 | -65.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.27 | 63.9 | -75.5 | 2.92 | -7.08 |